TheNewswire
08 Sept 2026, 22:00 UTC · 2d ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Analysis by Kasper Rasmussen · Founder & analyst
What the story claims
3 claims · each scored for market impact
Onco-Innovations Limited is settling $481,694 in debt by issuing 860,168 common shares to insiders and consultants. — While it removes a liability from the balance sheet, it creates equity dilution for existing shareholders.
-0.30The debt settlement involves related party transactions with the company's CEO and CFO. — Transactions with executives can raise corporate governance concerns and perceived conflicts of interest.
-0.20The shares for the debt settlement are being issued at a deemed price of $0.56 per share. — Establishes a concrete valuation benchmark for the shares in a recent transaction.
+0.10Which stocks this story touches
Continue reading
5 related stories
Search tags
The company is reducing its total indebtedness by settling debts through share issuance.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
TheNewswire
48m ago
